Health 'N' U Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.15 M
as on 13-12-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 25.62%
(FY 2022)
- Profit 13.28%
(FY 2022)
- Ebitda 36.42%
(FY 2022)
- Net Worth 84.60%
(FY 2022)
- Total Assets 14.05%
(FY 2022)
About Health 'N' U Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Naik, Suman Naik, and Nina Ishigami serve as directors at the Company.
- CIN/LLPIN
U85100MH2009PTC192268
- Company No.
192268
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2009
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Health 'N' U Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Naik  | Managing Director | 04-Jun-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suman Naik | Director | 08-May-2009 | Current |
Nina Ishigami  | Director | 14-Sep-2021 | Current |
Financial Performance of Health 'N' U Therapeutics.
Health 'N' U Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.62% increase. The company also saw a substantial improvement in profitability, with a 13.28% increase in profit. The company's net worth Soared by an impressive increase of 84.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Health 'N' U Therapeutics?
Unlock access to Health 'N' U Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Health 'N' U Therapeutics?
Health 'N' U Therapeutics has a workforce of 150 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Health 'N' U Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Health 'N' U Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
